Our previous work with these two compounds in HCC1806 breast cancer cells has documented a significant decrease in overall DNMT enzyme activity, with no significant effects on control MCF10A DNMT enzyme activity after 72 h of treatments [4]. Here, DNMT1 is linked to breast carcinoma.